How can physicians assess and minimize the risk for women with existing heart disease prior to pregnancy? As many women are waiting longer to become pregnant, is the spectrum of cardiovascular disease among pregnant women changing as well? Dr. Nazanin Moghbeli, founder and director of the Women's Cardiovascular Center at Penn Medicine, joins host Dr. Lee Freedman to discuss ways to optimize outcomes for pregnant women with structural heart disease, as well as how to minimize the risks of complications that can arise during pregnancy for these patients. Dr. Moghbeli specifically talks about recommendations for women with peripartum cardiomyopathy, pulmonary hypertension, preeclampsia and congenital heart disease.
Produced in Cooperation with
